Refresh

Natco Pharma Ltd. - Research Center

524816 NATCOPHARM Group (A) BSE data
Back to Company

Results

Statement

More

Quarterly results in brief
(Rs crore)
Dec' 23 Sep' 23 Jun' 23 Mar' 23 Dec' 22

Sales

625.30 930.50 1,048.30 781.20 413.00

Operating profit

238.30 442.30 503.70 327.70 67.50

Interest

3.80 3.00 3.20 1.20 3.00

Gross profit

264.00 464.00 515.10 344.00 83.10

EPS (Rs)

10.73 20.12 22.64 13.92 2.04
Quarterly  results in details
Dec' 23 Sep' 23 Jun' 23 Mar' 23 Dec' 22

Other income

29.50 24.70 14.60 17.50 18.60

Stock adjustment

7.40 7.50 32.00 53.40 -18.80

Raw material

92.20 166.60 136.10 146.30 132.80

Power and fuel

- - - - -

Employee expenses

103.90 106.80 119.20 97.30 91.90

Excise

- - - - -

Admin and selling expenses

- - - - -

Research and development expenses

- - - - -

Expenses capitalised

- - - - -

Other expenses

183.50 207.30 257.30 156.50 139.60

Provisions made

- - - - -

Depreciation

40.40 40.00 39.90 37.60 38.10

Taxation

31.60 63.80 69.90 52.30 7.70

Net profit / loss

192.00 360.20 405.30 254.10 37.30

Extra ordinary item

- - - - -

Prior year adjustments

- - - - -

Equity capital

35.80 35.80 35.80 36.50 36.50

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

- - - - -

Agg.of non promotoholding (%)

- - - - -

OPM (%)

38.11 47.53 48.05 41.95 16.34

GPM (%)

40.32 48.58 48.46 43.07 19.25

NPM (%)

29.32 37.71 38.13 31.81 8.64
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com